Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Vascular remodeling is central to the pathophysiology of hypertension and atherosclerosis. Recent evidence suggests that vasoconstrictive substances, such as angiotensin II (AII), may function as a vascular smooth muscle growth promoting substance. To explore the role of the counterregulatory hormon...
שמור ב:
| הוצא לאור ב: | J Clin Invest |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
1990
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296921/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2173726/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114893 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|